Katherine Feingold
Psychiatry · Livingston, NJNPI 1447476155
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 321 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 321 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$786
- Supernus Pharmaceuticals, Inc.$692
- Neos Therapeutics, LP$312
- Axsome Therapeutics, Inc.$289
- Ironshore Pharmaceuticals Inc.$283
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,276100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,024 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $786 |
| Supernus Pharmaceuticals, Inc. | 27 | $692 |
| Neos Therapeutics, LP | 26 | $312 |
| Axsome Therapeutics, Inc. | 12 | $289 |
| Ironshore Pharmaceuticals Inc. | 12 | $283 |
| Lundbeck LLC | 17 | $266 |
| Otsuka America Pharmaceutical, Inc. | 18 | $242 |
| Tris Pharma Inc | 15 | $219 |
| Johnson & Johnson | 11 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $141 |
| Harmony Biosciences LLC | 2 | $134 |
| Corium, LLC | 8 | $110 |
| Validus Pharmaceuticals LLC | 6 | $79 |
| Jazz Pharmaceuticals Inc. | 5 | $74 |
| Rhodes Pharmaceuticals L.p. | 5 | $69 |
| Sunovion Pharmaceuticals Inc. | 4 | $59 |
| Alkermes, Inc. | 3 | $55 |
| Shire North American Group Inc | 4 | $52 |
| Vertical Pharmaceuticals, LLC | 3 | $45 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Neurocrine Biosciences, Inc. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Adlon Therapeutics L.p. | 2 | $26 |
| Avion Pharmaceuticals | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| OWP Pharmaceuticals, Inc. | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,276 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylphenidate Hcl | 15 | $476 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 26 | $453 |
| Sertraline Hcl | 16 | $161 |
| Gabapentin | 12 | $115 |
| Alprazolam | 16 | $110 |
| Zolpidem Tartrate | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Livingston
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Leon RosenbergCherry Hill$257K
- Lloyd AlceraMarlton$187K
- Gary SmallHackensack$170K
- Shankar SrinivasanParsippany$155K
- Matthew PiteraToms River$153K
- Boris BorodulinEast Brunswick$116K
- Anthony RostainCamden$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.